PRESS-RELEASE ·Filed May 7, 2026

SIGA

SIGA Technologies Inc.
BEARISH
Impact 6/10
Horizonweeks Processed4mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▼ Bearish

Monitor Q2 2026 for actual delivery of $13M oral TPOXX to international customer; any delay or shortfall could further pressure the stock. The special dividend payout reduced cash reserves, leaving limited buffer for operations without new contracts.

DirectionBearish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
SIGA ▼ -32.50% at T+60d
SHORT call ✓ call won +32.50% · α vs SPY +37.34% · entry $4.80 → $3.24
Entry anchored
May 7, 03:59 PM ET
via exchange tick
T+1d
-5.21%
call +5.21% · α +5.44%
$4.55
settled 5mo ago
T+5d
-11.25%
call +11.25% · α +12.71%
$4.26
settled 5mo ago
T+20d
-10.42%
call +10.42% · α +10.44%
$4.30
settled 4mo ago
T+60d
-32.50%
call +32.50% · α +37.34%
$3.24
settled 8w ago

Price Chart

Loading chart...

Executive Summary

SIGA reported Q1 2026 total revenues of $6.2M (down 11% YoY) and a net loss of $3.5M vs $0.4M loss a year ago, driven by a 40% decline in product sales. Forward guidance points to $13M oral TPOXX delivery in Q2 and $26M IV TPOXX by end of Q3, but the sharp earnings deterioration weighs on sentiment.

Key Financial Metrics

EPS
$-0.05
Revenue
$6.2M
-11.4% YoY

Key Facts

  • Q1 2026 total revenues $6.2M vs $7.0M YoY (down 11%)
  • Product sales $3.5M vs $5.8M YoY (down 40%)
  • Net loss widened to $3.5M from $0.4M YoY
  • Diluted loss per share $(0.05) vs $(0.01) YoY
  • Expects $13M oral TPOXX delivery to Asia-Pacific customer in Q2 2026
  • Expects $26M IV TPOXX delivery to US SNS by end of Q3 2026
  • Paid special cash dividend of $0.60 per share on April 23, 2026

Financial Impact

Revenue decline of 11% YoY and net loss increase of $3.1M

revenuenet incomeproduct sales

Risk Factors

  • Concentration on government and limited international contracts
  • Declining product sales trend may continue without new orders
  • Cash burn from operating losses and dividend reduces financial flexibility

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3290508
3 reports for SIGA
Performance horizon
Filters
Rows
Reports for SIGA — sortable, filterable
TypeNow
May 8, 2026
20w ago
DEFA14A
NEUTRAL ★ 2/10
$4.55 $3.15▼ −30.77%▼ −35.16%$3.37 (−25.93%)
May 7, 2026
21w ago
Press Release
BEARISH ★ 6/10
$4.80 $3.24▲ +32.50%▲ +37.34%$3.37 (+29.79%)
Mar 26, 2026
27w ago
Press Release
NEUTRAL ★ 4/10
$4.69 $4.34▼ −7.43%▼ −23.50%$3.37 (−28.12%)
Showing 3 of 3

US Market Status

Market Open — Closes in 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 7, 2026